Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Lindner, AK; Pichler, M; Thurnher, M; Pichler, R.
Targeting c-Met to Improve Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma.
Eur Urol. 2022; 81(1): 1-2.
Doi: 10.1016/j.eururo.2021.10.025
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Pichler Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- c-Met inhibition has direct antitumor effects on proliferation, angiogenesis, and metastasis, and indirect antitumor effects via prevention of the induction of immunosuppressive mechanisms (PD-L1, TGFβ, IDO1). c-Met inhibition is key to overcome resistance to immune checkpoint inhibition and to maximize the efficacy of immunotherapy.